beta-arrestin

Beta-arrestin is the cell's off-switch and second courier for G-protein-coupled receptors. After a receptor has been firing for a while, beta-arrestin moves in, caps it, and disconnects it from its G protein — but, surprisingly, it can also start a second, separate signaling conversation of its own.

The sequence works like this: once a receptor is activated, GPCR kinases (GRKs) phosphorylate its tail; beta-arrestin then binds the phosphorylated receptor, sterically blocking further G-protein coupling (desensitization) and recruiting machinery that internalizes the receptor by endocytosis. From the membrane and from inside vesicles, beta-arrestin also scaffolds other signaling proteins (such as MAP kinases), driving G-protein-independent pathways.

This dual role gave rise to the idea of biased agonism: a drug can be designed to favor either the G-protein arm or the beta-arrestin arm of the same receptor. Researchers hoped, for example, for opioids that engage G-protein analgesia while sparing beta-arrestin-linked side effects; results have been mixed and the simple version of that hypothesis is now debated, but beta-arrestin remains central to how receptors are silenced, recycled, and rewired.